Diabetic Foot Ulcer Treatment Market Scope And Analysis

  • Report Code : TIPRE00022321
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 231
Buy Now

Diabetic Foot Ulcer Market Scope and Analysis Report by 2030

Buy Now


Diabetic Foot Ulcer Market Report Scope

Report Attribute Details
Market size in 2022 US$ 7.47 Billion
Market Size by 2030 US$ 12.24 Billion
Global CAGR (2022 - 2030) 6.4%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By Ulcer Type
  • Neuropathic Ulcers
  • Ischemic Ulcers
  • Neuro-ischemic Ulcers
By Treatment Type
  • Advanced Wound Care Dressings
  • Biologics
  • Therapy Device
By Infection Severity
  • Moderate
  • Mild
  • Severe
By End User
  • Hospitals
  • Ambulatory Surgery Centers
  • Home Care
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Convatec Group Plc
  • 3M Co
  • Coloplast AS
  • Smith Nephew Plc
  • B Braun SE
  • Molnlycke Health Care AB
  • MiMedx Group Inc
  • URGO MEDICAL Australia Pty Ltd
  • Medline Industries LP
  • Competitive Landscape and Key Companies:

    Convatec Group Plc, 3M Co, Coloplast AS, Smith & Nephew Plc, B. Braun SE, Molnlycke Health Care AB, MiMedx Group Inc, URGO MEDICAL Australia Pty Ltd, Medline Industries LP, and Organogenesis Inc are among the prominent players operating in the diabetic foot ulcer market. These companies focus on new technologies, advancements in existing products, and geographic expansions to meet the growing consumer demand worldwide and increase their product range in specialty portfolios.